These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3523495)

  • 1. Bone marrow transplantation with ciclosporin.
    Gratwohl A; Speck B
    Prog Allergy; 1986; 38():404-31. PubMed ID: 3523495
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of immunosuppressive drugs for prevention of graft-v-host disease after human HLA matched bone marrow transplantation.
    Gluckman E; Devergie A; Lokiec F; Traineau R; Cosset JM; Lemercier N; Varrin F; Cavazzana M; de Castro H; Meletis J
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):61-5. PubMed ID: 3321648
    [No Abstract]   [Full Text] [Related]  

  • 3. Combination prophylactic immunosuppression in bone marrow transplantation.
    Szer J
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3011-2. PubMed ID: 2650415
    [No Abstract]   [Full Text] [Related]  

  • 4. [Use of cyclosporin A in 5 leukemia patients receiving allogeneic bone marrow transplantation].
    Akao Y; Sao H; Tahara T; Yoshikawa H; Yoshikawa S; Morishima Y; Hiraiwa A; Naoe T
    Rinsho Ketsueki; 1984 Sep; 25(9):1417-26. PubMed ID: 6394783
    [No Abstract]   [Full Text] [Related]  

  • 5. The correlation of cyclosporine serum and whole blood concentrations with toxicity and efficacy after human marrow transplantation.
    Britton K; Atkinson K; Downs K; Biggs J
    Transplant Proc; 1985 Apr; 17(2):1667-70. PubMed ID: 3885501
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclosporine in children.
    Polchi P; Lucarelli G; Galimberti M; Moretti L
    Prog Clin Biol Res; 1989; 309():333-48. PubMed ID: 2675102
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cyclosporin A].
    Gabrielli A; Rupoli S
    Recenti Prog Med; 1985 Jun; 76(6):326-31. PubMed ID: 3903888
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cyclosporin in allogeneic bone marrow transplantation].
    Klingemann HG; Storb R
    Internist (Berl); 1985 Sep; 26(9):569-74. PubMed ID: 3905679
    [No Abstract]   [Full Text] [Related]  

  • 9. Cyclosporin A: use in preventing graft versus host disease.
    Klemm P
    Oncol Nurs Forum; 1985; 12(5):25-32. PubMed ID: 3898028
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclosporin a: a new era in organ transplantation.
    DeBakey ME
    Compr Ther; 1984 Feb; 10(2):7-15. PubMed ID: 6368108
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic studies of cyclosporine in bone marrow transplantation.
    Yee GC
    Transplant Proc; 1990 Jun; 22(3):1327-30. PubMed ID: 2190394
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclosporin A (CsA): pharmacokinetics, clinical monitoring and pharmacodynamics in bone marrow transplantation (BMT).
    Carreras Pons E
    Prog Clin Biol Res; 1989; 309():325-32. PubMed ID: 2675101
    [No Abstract]   [Full Text] [Related]  

  • 13. [Two cases of allogeneic bone marrow transplantation with psychoneurological symptoms possibly due to hypomagnesemia caused by cyclosporin A].
    Urase F; Shimotsuma H; Hamazaki H; Ashida T; Satoh M; Sueyoshi A; Tsubaki K; Horiuchi A
    Rinsho Ketsueki; 1987 Dec; 28(12):2198-203. PubMed ID: 3330740
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of graft versus host disease following allogeneic bone marrow transplantation.
    Powles RL; Goss GD; Millar J; Maitland J; Borthwick-Clark C; Al-Jundi A
    Tokai J Exp Clin Med; 1985 Jun; 10(2-3):133-8. PubMed ID: 3914738
    [No Abstract]   [Full Text] [Related]  

  • 15. [Graft-versus-host disease (author's transl)].
    Gratwohl A
    Schweiz Rundsch Med Prax; 1982 Jan; 71(4):129-31. PubMed ID: 7041107
    [No Abstract]   [Full Text] [Related]  

  • 16. Membranous nephropathy after bone marrow transplantation in ciclosporin treatment.
    Müller GA; Müller CA; Markovic-Lipkowski J; Bross-Bach U; Schmidt H; Ehninger G; Bohle A; Risler T
    Nephron; 1989; 51(4):555-6. PubMed ID: 2662038
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prevention of graft versus host disease by in vitro immunodepletion of the graft].
    Maraninchi D
    Nouv Rev Fr Hematol (1978); 1985; 27(6):349-50. PubMed ID: 3912729
    [No Abstract]   [Full Text] [Related]  

  • 18. [1st seminar of the Study Group on Bone Marrow Grafting on immunodepletion in the prevention of the graft-vs-host reaction. Marseilles, France, 4-6 October 1984. Abstracts].
    Nouv Rev Fr Hematol (1978); 1985; 27(6):351-75. PubMed ID: 3912730
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of monoclonal antibodies in human bone marrow transplantation.
    Neudorf SM; Filipovich AH; Kersey JH
    Prog Clin Biol Res; 1984; 149():367-77. PubMed ID: 6377327
    [No Abstract]   [Full Text] [Related]  

  • 20. [Anatomo-clinical presentation of graft-versus-host disease treated with cyclosporin A].
    Al Rustom K; Pierard-Franchimont C; Pierard GE
    Dermatologica; 1985; 171(2):65-71. PubMed ID: 3899758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.